ClinicalTrials.Veeva

Menu

The Impact of Ischemic Preconditioning on Exercise Performance and Physiological Function

Z

Ziyue Ou

Status

Completed

Conditions

Autonomic Nervous System (ANS) Functioning and Mood State
Ischemic Preconditioning

Treatments

Procedure: Ischemic Preconditioning
Procedure: Sham (No Treatment)

Study type

Interventional

Funder types

Other

Identifiers

NCT07146399
2023LCLL-81

Details and patient eligibility

About

Ischemic Preconditioning has been confirmed to prevent long-term ischemic damage to tissues, among which the improvement of autonomic nerve system function may be one of its mechanisms of action. In recent years, IPC has gradually been applied to enhance athletic performance and accelerate postexercise recovery; however, there has been limited research on the effects of IPC on ANS function and competitive condition before and after exercise. This study investigated the effects of IPC on ANS function before and after sport-specific testing in taekwondo athletes. The objectives of our study are (1) to investigate the impact of IPC on two indicators of autonomic nervous function-HRV and HRR-and (2) to reveal the coordinating effect of IPC on the sympathetic and parasympathetic nervous systems during the warm-up phase and after specific testing in taekwondo athletes. The investigators hypothesize that IPC enhances sympathetic drive during the warm-up phase and rapidly activates the parasympathetic nervous system postexercise, which is accompanied by improvements in the athletes' competitive condition.

Enrollment

15 patients

Sex

Male

Ages

18 to 22 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Taekwondo athletes with a national ranking of level two or higher, including those placed in the top three at the Provincial Professional Taekwondo Championship (combat) and the top eight at the National Professional Taekwondo Championship (combat);
  • adult males aged 18 years or older;
  • regular participation in specialized Taekwondo training for the past three months.
  • All the subjects were from the same team.

Exclusion criteria

  • consumption of alcohol or caffeine within 24 hours prior to the experiment;
  • engagement in strenuous physical activity within 24 hours before the experiment;
  • presence of acute or chronic diseases, including cardiovascular diseases, anxiety disorders, and metabolic diseases;
  • use of creatine supplements

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

15 participants in 2 patient groups, including a placebo group

IPC Trial
Experimental group
Description:
220 mmHg
Treatment:
Procedure: Ischemic Preconditioning
SHAM Trial
Placebo Comparator group
Description:
20 mmHg
Treatment:
Procedure: Sham (No Treatment)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems